Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Pharmacyclics Inc (PCYC)’

top 10 Ethereum exchanges to Buy and Sell ETH

15 Most Successful Penny Stocks in History

Among tens of thousands of penny stocks, only a few made it big, so let’s take a look at 15 most successful penny stocks in history. While most......(read more)
Felix Baker - Baker Bros.

Baker Bros. Advisors Dump 75% Of Stake In XOMA Corp (XOMA) after Late-Stage Study Failure

Was Baker Bros. Advisors‘ investment in XOMA Corp (NASDAQ:XOMA) a mistake? According to a recent filing with the Securities and Exchange Commission......(read more)
best paying jobs

Pharmacyclics, Inc. (PCYC), Horizon Pharma PLC (HZNP), Auspex Pharmaceuticals Inc (ASPX): Hedge Fund’s Cashing In On Highest Q1 Gainers

The first quarter is up, and our data analytics show that the top three gainers for the quarter were all biotechnology or biopharmaceutical companies......(read more)
Felix Baker - Baker Bros.

Baker Bros. Advisors Hits the Jackpot with Pharmacyclics Inc (PCYC) Sale; Incyte Corporation (INCY) Among Fund’s Other Top Picks

Julian Baker and Felix Baker‘s Baker Bros. Advisors’ top pick from the end of 2014 has paid off for the fund in a big way in 2015. AbbVie Inc......(read more)
Felix Baker - Baker Bros.

Mirati Therapeutics Inc. (MRTX): Baker Bros. Advisors Increases Stake in Growing Stock

Julian Baker and Felix Baker’s Baker Bros. Advisors recently disclosed an increase of around 929,700 shares to its position in Mirati Therapeutics,......(read more)
Pharmacyclics, Inc. (NASDAQ:PCYC)

Baker Bros Reveals New Stake in Aquinox Pharmaceuticals (AQXP)

In a new filing with the SEC, Julian Baker and Felix Baker’s Baker Bros. Advisors revealed new stake in Aquinox Pharmaceuticals Inc (NASDAQ:AQXP).......(read more)
ACADIA Pharmaceuticals Inc. (ACAD)

Baker Bros. Advisors’ Latest Moves Involve ACADIA Pharmaceuticals Inc. (ACAD) & Synageva Biopharma Corp (TRMS)

Julian Baker and Felix Baker’s hedge fund, Baker Bros. Advisors, has recently tweaked its holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and......(read more)
MEI Pharma

Baker Bros. Advisors Reduces Exposure to MEI Pharma Inc (MEIP) to 3.4%

Julian and Felix Baker‘s Baker Bros. Advisors has decreased its stake in MEI Pharma Inc (NASDAQ:MEIP) to 746,521 shares, from 1,130,317 shares......(read more)
Seattle Genetics, Inc. (NASDAQ:SGEN)

Baker Bros. Strengthens Position in Seattle Genetics, Inc. (SGEN)

Julian Baker and Felix Baker have increased their exposure to Seattle Genetics, Inc. (NASDAQ:SGEN) even higher. In a newly amended filing with the SEC......(read more)
Bill Miller

Hedge Fund News: Bill Miller, Richard Perry & Alphonse Fletcher

Miller: No ‘extraordinary value’ left in US markets (InvestmentWeek) Legg Mason’s Bill Miller is struggling to find the ‘extraordinary......(read more)
Sanofi SA (ADR) (NYSE:SNY)

Sanofi SA (ADR) (SNY), Roche Holding Ltd. (ADR) (RHHBY), GlaxoSmithKline plc (ADR) (GSK): Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia?

There is perhaps nothing scarier than a cancer diagnosis. A study in 2010 conducted by Cancer Research UK demonstrated this to the “T,” when......(read more)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN), Pharmacyclics, Inc. (PCYC), Aegerion Pharmaceuticals, Inc. (AEGR), Raptor Pharmaceutical Corp. (RPTP): Have These Four Biotechs Peaked?

Biotechnology stocks often trade with excessive valuations, until one day, large losses occur. The best way to protect yourself is to be logical when......(read more)
Santarus, Inc. (NASDAQ:SNTS)

Santarus, Inc. (SNTS), Pharmacyclics, Inc. (PCYC), Ariad Pharmaceuticals, Inc. (ARIA): Should You Jump on This Biotech After Profit-Taking?

After a truly remarkable 20-month 650% gain, shares of Santarus, Inc. (NASDAQ:SNTS) have fallen by more than 20% since its all-time high in early August......(read more)
Dr. Reddy's Laboratories Limited (ADR) (NYSE:RDY)

Hedge Funds Are Dumping Dr. Reddy’s Laboratories Limited (ADR) (RDY)

To many of your fellow Dr. Reddy’s Laboratories Limited (ADR) (NYSE:RDY) investors, hedge funds are perceived as overrated, outdated investment......(read more)
Novo Nordisk A/S (ADR) (NYSE:NVO)

Is Novo Nordisk A/S (ADR) (NVO) Going to Burn These Hedge Funds?

Should Novo Nordisk A/S (ADR) (NYSE:NVO) investors track the following data? In the 21st century investor’s toolkit, there are a multitude of metrics......(read more)
Pharmacyclics, Inc. (NASDAQ:PCYC)

Pharmacyclics, Inc. (PCYC), Johnson & Johnson (JNJ): The FDA Loves This Drug

It should come as no surprise to anyone that the Food and Drug Administration granted a priority review for Pharmacyclics, Inc. (NASDAQ:PCYC) and Johnson......(read more)
Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (JNJ), Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): The Biggest Winners of the FDA’s Breakthrough Designation

Designed as a way to bring potentially life-changing drugs to pharmacy shelves faster than ever, the Food and Drug Administration Safety and Innovation......(read more)
Amgen, Inc. (NASDAQ:AMGN)

Amgen, Inc. (AMGN), Astex Pharmaceuticals, Inc. (ASTX), Pharmacyclics, Inc. (PCYC): This Week in Biotech

With the SPDR S&P Biotech Index up 35% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into......(read more)
Pharmacyclics, Inc. (NASDAQ:PCYC)

What Hedge Funds Think About Pharmacyclics, Inc. (PCYC)

In today’s marketplace, there are many metrics market participants can use to track publicly traded companies. A pair of the most innovative are hedge......(read more)
Allergan, Inc. (NYSE:AGN)

Allergan, Inc. (AGN): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

Is Allergan, Inc. (NYSE:AGN) a buy? In the eyes of many of your fellow readers, hedge funds are seen as useless, old financial vehicles of an era lost......(read more)
Forest Laboratories, Inc. (NYSE:FRX)

Forest Laboratories, Inc. (FRX): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged

Is Forest Laboratories, Inc. (NYSE:FRX) a sell? If you were to ask many investors, hedge funds are seen as delayed, old financial tools of an era lost......(read more)
Pharmacyclics, Inc. (NASDAQ:PCYC)

Pharmacyclics, Inc. (PCYC), Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG): This Small Company Is Winning the War Against Blood Cancer

About 15,680 Americans are diagnosed with chronic lymphocytic leukemia, or CLL, and approximately 5,000 new cases of mantle cell lymphoma, or MCL, occur......(read more)
Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Regeneron Pharmaceuticals Inc (REGN), Pharmacyclics, Inc. (PCYC): Is There Pipeline Potential in These Biotech Stocks?

It is not uncommon for a biotechnology company to be valued solely on the potential of one drug. For many small and midcap biotechs, the potential of......(read more)
Pharmacyclics, Inc. (NASDAQ:PCYC)

Pharmacyclics, Inc. (PCYC), Annaly Capital Management, Inc. (NLY): Shorts Are Piling Into These Stocks. Should You Be Worried?

The best thing about the stock market is that you can make money in either direction. Historically, stock indexes have tended to trend up over the long......(read more)
Pharmacyclics, Inc. (NASDAQ:PCYC)

Pharmacyclics, Inc. (PCYC) Set to Glide Higher

Pharmacyclics, Inc. (NASDAQ:PCYC) has been a good company to invest in, especially if you had bought shares back in 2009 when it traded around $1 per......(read more)
Celgene Corporation (NASDAQ:CELG)

What Does Celgene Corporation (CELG)’s Failed Trial Mean for Investors?

Early this morning, Celgene Corporation (NASDAQ:CELG) announced that it was discontinuing the phase 3 ORIGIN Trial evaluating Revlimid (lenalidomide)......(read more)
Johnson & Johnson (JNJ)

Can Earnings Push Johnson & Johnson (JNJ) to New Heights?

Johnson & Johnson (NYSE:JNJ) is scheduled to release its quarterly earnings report tomorrow, and as a huge health-care conglomerate with a strong......(read more)
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Inovio Pharmaceuticals Inc (INO), Alnylam Pharmaceuticals, Inc. (ALNY): This Week in Biotech

With the SPDR S&P Biotech Index up 33% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......(read more)
Pharmacyclics, Inc. (NASDAQ:PCYC)

Pharmacyclics, Inc. (PCYC): Will This Be the Breakthrough of All Breakthrough Therapy Drugs?

In July 2012, the Food and Drug Administration Safety and Innovation Act was signed into law; and little did we know at the time, but the drug development......(read more)
Pharmacyclics, Inc. (NASDAQ:PCYC)

Pharmacyclics, Inc. (PCYC), Johnson & Johnson (JNJ) File for Marketing Approval for Ibrutinib

Pharmacyclics, Inc. (NASDAQ:PCYC) and development partner Janssen, a division of Johnson & Johnson (NYSE:JNJ), announced on Wednesday that a New......(read more)
Pharmacyclics, Inc. (NASDAQ:PCYC)

Why Pharmacyclics, Inc. (PCYC) Shares Vaulted Higher

Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case......(read more)
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals, Inc. (ONXX), Pharmacyclics, Inc. (PCYC): Will This Biotech Acquisition Buzz Lead to More Buyouts?

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is trading higher after rejecting a takeover bid. As other stocks in its sector also trade higher in sympathy......(read more)
Amgen, Inc. (NASDAQ:AMGN)

Amgen, Inc. (AMGN) Stirs the Pot in the Cancer-Related Sector

Several companies are fighting to be the first to release a treatment or cure for cancer that is a game-changer, and this battle has created a field where......(read more)
ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Inc. (ACAD): Look Before You Leap With This Company

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is a bio-pharmaceutical company that specializes in the innovation of small-molecule drugs that are used to......(read more)
Affymax, Inc. (NASDAQ:AFFY)

Oncolytics Biotech, Inc. (USA) (ONCY): This High-Risk, High-Reward Biotech Is Worth a Look

Let me preface this by saying that investing in the biotech sector can sometimes be nothing more than speculating. The fortunes of a biotechnology can......(read more)
ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Inc. (ACAD) Soars On Hedge Fund Investment

One of the best ways that retail investors can try to decide which stocks will make for a promising investment is to look at what the hedge funds are......(read more)
Rite Aid Corporation (NYSE:RAD)

Apple Inc. (AAPL), Alcatel Lucent SA (ADR) (ALU): 4 Stocks On The Verge Of Breaking Out!

Rite Aid Corporation (NYSE:RAD) has been my favorite stock for the better part of the last year. I first began covering the stock when it was at $1.00......(read more)

Bristol Myers Squibb Co. (BMY), Pharmacyclics, Inc. (PCYC): Hedging Against Leukemia

As I noted 11 weeks ago, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing......(read more)

Corning Incorporated (GLW), Pharmacyclics, Inc. (PCYC), 3D Systems Corporation (DDD): How To Play Them

An analyst upgrade can sometimes be highly useful in allowing you to learn about a new company that might have flown under-the-radar. With the markets......(read more)

Sarepta Therapeutics Inc (SRPT), Pharmacyclics, Inc. (PCYC): Are These Billion-Dollar Biotechs Overvalued?

Biotechs with market caps of a billion dollars or more are a dime a dozen. Well, actually, they’re more like $12 billion or more a dozen, but you......(read more)

Biogen Idec Inc. (BIIB), Pharmacyclics, Inc. (PCYC), Immunomedics, Inc. (IMMU), and Tackling Cancer, Non-Hodgkin Lymphoma’s Biggest Current & Upcoming Players

As I noted seven weeks ago, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing......(read more)

Pharmacyclics, Inc. (PCYC), Keryx Biopharmaceuticals (KERX): These Cutting-Edge Science Stocks Are Soaring

Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you’d like to add some biotech and genome-focused......(read more)

Pfizer Inc. (PFE) & More…a ‘Breakthrough’ May Be on the Way for Breast Cancer Patients

The process of developing a drug from start to finish is incredibly arduous, usually involves around $1 billion in costs, and can take upwards of a decade......(read more)

Johnson & Johnson (JNJ), And Why The FDA’s Latest Designation is More Bling Than Bite

If one “Breakthrough Therapy Designation” is good, three must be great. That is, if we knew what the designation was really worth. Johnson......(read more)
Infinity Pharmaceuticals Inc. (NASDAQ:INFI)

3 Humongous Health-Care Stocks This Week: Infinity Pharmaceuticals Inc. (INFI)

There’s power in positive thinking. The late author Norman Vincent Peale made plenty of money off that philosophy. Some investors made lots of money......(read more)
3D Systems Corporation (NYSE:DDD)

Wildly Growing Stocks, With a Hefty Dividend, Too: 3D Systems Corporation (DDD) and More

Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you’d like to add some small-cap growth stocks......(read more)
Pharmacyclics, Inc. (NASDAQ:PCYC)

Whoa! These 3 Stocks Are on the Ball: Pharmacyclics, Inc. (PCYC)

With the president calling for new initiatives on the federal minimum wage, immigration, gun control, and early childhood education, the Dow Jones Industrial......(read more)
Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (GILD): A Pharmaceutical Growth Story You Can’t Afford To Miss

Gilead Sciences, Inc. (NASDAQ:GILD) is the world’s largest maker of HIV drugs, but has taken on a number of new initiatives to enter other areas of......(read more)
Johnson & Johnson (NYSE:JNJ)

The FDA Made Biotech Investing Harder (But More Lucrative): Johnson & Johnson (JNJ)

The secret to successful biotech investing is to understand how the industry works better than the next guy. Following the crowd is no way to make money......(read more)
AbbVie Inc (NYSE:ABBV)

This Week in Biotech: AbbVie Inc (ABBV) and More

With the SPDR S&P Biotech Index up 20% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......(read more)